RE-BVS – Piemonte Repository

Sfoglia per AUTORE
NIELSEN T
Collezione AOU Città della Salute di Torino

Items : 5

Prognostic impact of somatic mutations in diffuse large B-cell lymphoma and relationship to cell-of-origin: data from the phase III GOYA study. in Haematologica / Haematologica. 2020 Sep 1;105(9):2298-2307. doi: 10.3324/haematol.2019.227892.

2020
AOU Città della Salute di Torino

Bolen CR; Klanova M; Trneny M; Sehn LH; He J; Tong J; Paulson JN; Kim E; Vitolo U; Di Rocco A; Fingerle-Rowson G; Nielsen T; Lenz G; Oestergaard MZ;

Integration of cell of origin into the clinical CNS International Prognostic Index improves CNS relapse prediction in DLBCL. in Blood / Blood. 2019 Feb 28;133(9):919-926. doi: 10.1182/blood-2018-07-862862. Epub 2019 Jan 7.

2019
AOU Città della Salute di Torino

Klanova M; Sehn LH; Bence-Bruckler I; Cavallo F; Jin J; Martelli M; Stewart D; Vitolo U; Zaja F; Zhang Q; Mattiello F; Sellam G; Punnoose EA; Szafer-Glusman E; Bolen CR; Oestergaard MZ; Fingerle-Rowson GR; Nielsen T; Trneny M;

Prognostic Impact of Natural Killer Cell Count in Follicular Lymphoma and Diffuse Large B-cell Lymphoma Patients Treated with Immunochemotherapy. in Clinical cancer research : an official journal of the American Association for Cancer Research / Clin Cancer Res. 2019 Aug 1;25(15):4634-4643. doi: 10.1158/1078-0432.CCR-18-3270. Epub 2019 May 3.

2019
AOU Città della Salute di Torino

Bolen CR; Cardona A; Spielewoy N; Sahin D; Knapp A; Zeuner H; Goede V; Bazeos A; Vitolo U; Sehn LH; Marcus R; Hiddemann W; Trn?ný M; Oestergaard MZ; Klanova M; Klein C; Venstrom JM; Nielsen T; Fingerle-Rowson G;

Obinutuzumab or Rituximab Plus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone in Previously Untreated Diffuse Large B-Cell Lymphoma. in Journal of clinical oncology : official journal of the American Society of Clinical Oncology / J Clin Oncol. 2017 Nov 1;35(31):3529-3537. doi: 10.1200/JCO.2017.73.3402. Epub 2017 Aug 10.

2017
AOU Città della Salute di Torino

Vitolo U; Trn?ný M; Belada D; Burke JM; Carella AM; Chua N; Abrisqueta P; Demeter J; Flinn I; Hong X; Kim WS; Pinto A; Shi YK; Tatsumi Y; Oestergaard MZ; Wenger M; Fingerle-Rowson G; Catalani O; Nielsen T; Martelli M; Sehn LH;

Thirty-Month Complete Response as a Surrogate End Point in First-Line Follicular Lymphoma Therapy: An Individual Patient-Level Analysis of Multiple Randomized Trials. in Journal of clinical oncology : official journal of the American Society of Clinical Oncology / J Clin Oncol. 2017 Feb 10;35(5):552-560. doi: 10.1200/JCO.2016.70.8651. Epub 2016 Dec 28.

2017
AOU Città della Salute di Torino

Sargent DJ; Salles G; Zucca E; Morschhauser F; Ladetto M; Hoster E; Fowler NH; Valente N; Fu T; De Bedout S; Nielsen T; Ghielmini M; Gyan E; Peterson BA; Vitolo U; Hochster H; Kimby E; Hagenbeek A; Herold M; Marcus R; Hiddemann W; Flowers CR; Shi Q;